JP2024531150A5 - - Google Patents
Info
- Publication number
- JP2024531150A5 JP2024531150A5 JP2024508009A JP2024508009A JP2024531150A5 JP 2024531150 A5 JP2024531150 A5 JP 2024531150A5 JP 2024508009 A JP2024508009 A JP 2024508009A JP 2024508009 A JP2024508009 A JP 2024508009A JP 2024531150 A5 JP2024531150 A5 JP 2024531150A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- item
- composition according
- rsv
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163231568P | 2021-08-10 | 2021-08-10 | |
| US63/231,568 | 2021-08-10 | ||
| US202263367103P | 2022-06-27 | 2022-06-27 | |
| US63/367,103 | 2022-06-27 | ||
| PCT/US2022/074699 WO2023019131A1 (en) | 2021-08-10 | 2022-08-09 | Virus-like particle vaccine for respiratory syncytial virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531150A JP2024531150A (ja) | 2024-08-29 |
| JP2024531150A5 true JP2024531150A5 (https=) | 2025-08-20 |
Family
ID=85200421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508009A Pending JP2024531150A (ja) | 2021-08-10 | 2022-08-09 | 呼吸器多核体ウイルスに対するウイルス様粒子ワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240350616A1 (https=) |
| EP (1) | EP4384535A4 (https=) |
| JP (1) | JP2024531150A (https=) |
| KR (1) | KR20240046885A (https=) |
| AU (1) | AU2022326546A1 (https=) |
| CA (1) | CA3228461A1 (https=) |
| IL (1) | IL310628A (https=) |
| MX (1) | MX2024001867A (https=) |
| WO (1) | WO2023019131A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5762408B2 (ja) * | 2009-08-13 | 2015-08-12 | クルセル ホランド ベー ヴェー | ヒト呼吸器合胞体ウイルス（ｒｓｖ）に対する抗体および使用方法 |
| EP2970398B1 (en) * | 2013-03-13 | 2024-05-08 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
| HUE073526T2 (hu) * | 2017-04-04 | 2026-01-28 | Univ Washington | Önmagát összeállító fehérje nanostruktúrák, amelyek paramyxovírus és/vagy pneumovírus F fehérjéket jelenítenek meg és azok használata |
| US11376317B2 (en) * | 2017-08-30 | 2022-07-05 | University Of Maryland, College Park | FcRn-targeted mucosal vaccination against RSV |
-
2022
- 2022-08-09 IL IL310628A patent/IL310628A/en unknown
- 2022-08-09 KR KR1020247007829A patent/KR20240046885A/ko active Pending
- 2022-08-09 CA CA3228461A patent/CA3228461A1/en active Pending
- 2022-08-09 AU AU2022326546A patent/AU2022326546A1/en active Pending
- 2022-08-09 MX MX2024001867A patent/MX2024001867A/es unknown
- 2022-08-09 WO PCT/US2022/074699 patent/WO2023019131A1/en not_active Ceased
- 2022-08-09 US US18/682,281 patent/US20240350616A1/en active Pending
- 2022-08-09 EP EP22856762.4A patent/EP4384535A4/en active Pending
- 2022-08-09 JP JP2024508009A patent/JP2024531150A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Garenne et al. | Child mortality after high-titre measles vaccines: prospective study in Senegal | |
| Simões et al. | Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in children | |
| Straus et al. | Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes | |
| JP2005533861A5 (https=) | ||
| Shahab et al. | Influenza virus | |
| JP2022514759A (ja) | ノロウイルスワクチン製剤及び方法 | |
| Lee et al. | Respiratory syncytial virus prevention: a new era of vaccines | |
| Powell | Response to live attenuated measles vaccine in children with severe kwashiorkor | |
| JP2024531150A5 (https=) | ||
| Kasel et al. | Human influenza: aspects of the immune response to vaccination | |
| JP2003531822A (ja) | 自己免疫疾患を治療するためのｔｈ−１免疫反応誘導サイトカインの拮抗薬 | |
| HUE026740T2 (en) | Treatment of Multiple Sclerosis (MS) with Campath-1H | |
| JPH10507175A (ja) | パラミクソウイルスワクチン用アジュバントとしてのインターロイキン−１２ | |
| Welliver | Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection | |
| JP2023535792A (ja) | コロナウイルス治療のための抗ｃｄ３抗体 | |
| Rammohan et al. | Subacute sclerosing panencephalitis after passive immunization and natural measles infection: role of antibody in persistence of measles virus | |
| Weisman | Respiratory syncytial virus (RSV) prevention and treatment: past, present, and future | |
| Grose et al. | Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host | |
| JP4053587B2 (ja) | 不活性化レスピラトリーシンシシャルウイルスワクチン | |
| IL310628A (en) | Virus-like particle vaccine for respiratory syncytial virus | |
| Siegrist | Vaccination strategies for children with specific medical conditions: a paediatrician's viewpoint | |
| CN119700949A (zh) | 一种重组呼吸道合胞病毒疫苗及其制备方法和应用 | |
| Carter et al. | Rational use of measles, mumps and rubella (MMR) vaccine | |
| EP0545951B1 (en) | Hrsv vaccine | |
| Imam et al. | Challenge of monkeys with Japanese B virus after immunization by West Nile infection plus Japanese B vaccine |